Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institutionsort descending Stage Project Objective Details
Heart Disease,
Danon Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Development Candidate, Proof of Concept
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Vision Loss iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Colon Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis,
Spinal Cord Injury
Embryonic Stem Cell,
iPS Cell
Cell imaging & tracking UCSD
Research Insights
Cancer Cancer Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Cystinosis,
Kidney Failure
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Clinical Trial, Phase 1 or Phase 1/2
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Parkinson's Disease Adult Stem Cell Gene-modified, donor cell therapy UCSF
IND
COVID-19 Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
HIV/AIDS,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test UCSF
Regulated Lab Test, Ready for Validation
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy UCSF
IND
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Alpha Thalassemia Major Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Type 1 diabetes Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Age-related macular degeneration Embryonic Stem Cell Biologic USC
Pre-IND/IDE or Equivalent
COVID-19 iPS Cell Small molecule therapy USC
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Gene-modified, donor cell therapy USC
Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis iPS Cell Nucleic acid based therapy USC
Development Candidate, Proof of Concept
Hearing Loss iPS Cell Model system development USC
Proof of Concept, Tool/Resources/Bottleneck
Type 1 diabetes Embryonic Stem Cell Donor cell therapy ViaCyte
Clinical Trial, Phase 1 or Phase 1/2
Inflammatory bowel disease Adult Stem Cell Donor cell therapy Vitabolus, Inc.
Development Candidate, Proof of Concept

Pages

Icon for csv export